572 related articles for article (PubMed ID: 7823959)
1. Characterization of mechanisms involved in transrepression of NF-kappa B by activated glucocorticoid receptors.
Scheinman RI; Gualberto A; Jewell CM; Cidlowski JA; Baldwin AS
Mol Cell Biol; 1995 Feb; 15(2):943-53. PubMed ID: 7823959
[TBL] [Abstract][Full Text] [Related]
2. CBP (CREB binding protein) integrates NF-kappaB (nuclear factor-kappaB) and glucocorticoid receptor physical interactions and antagonism.
McKay LI; Cidlowski JA
Mol Endocrinol; 2000 Aug; 14(8):1222-34. PubMed ID: 10935546
[TBL] [Abstract][Full Text] [Related]
3. Glucocorticoid-mediated gene suppression of rat cytokine-induced neutrophil chemoattractant CINC/gro, a member of the interleukin-8 family, through impairment of NF-kappa B activation.
Ohtsuka T; Kubota A; Hirano T; Watanabe K; Yoshida H; Tsurufuji M; Iizuka Y; Konishi K; Tsurufuji S
J Biol Chem; 1996 Jan; 271(3):1651-9. PubMed ID: 8576166
[TBL] [Abstract][Full Text] [Related]
4. Glucocorticoid inhibition of SP-A gene expression in lung type II cells is mediated via the TTF-1-binding element.
Alcorn JL; Islam KN; Young PP; Mendelson CR
Am J Physiol Lung Cell Mol Physiol; 2004 Apr; 286(4):L767-76. PubMed ID: 14633512
[TBL] [Abstract][Full Text] [Related]
5. Hsp90 inhibitors attenuate effect of dexamethasone on activated NF-kappaB and AP-1.
Tago K; Tsukahara F; Naruse M; Yoshioka T; Takano K
Life Sci; 2004 Mar; 74(16):1981-92. PubMed ID: 14967193
[TBL] [Abstract][Full Text] [Related]
6. Negative cross-talk between RelA and the glucocorticoid receptor: a possible mechanism for the antiinflammatory action of glucocorticoids.
Caldenhoven E; Liden J; Wissink S; Van de Stolpe A; Raaijmakers J; Koenderman L; Okret S; Gustafsson JA; Van der Saag PT
Mol Endocrinol; 1995 Apr; 9(4):401-12. PubMed ID: 7659084
[TBL] [Abstract][Full Text] [Related]
7. I kappa B/MAD-3 masks the nuclear localization signal of NF-kappa B p65 and requires the transactivation domain to inhibit NF-kappa B p65 DNA binding.
Ganchi PA; Sun SC; Greene WC; Ballard DW
Mol Biol Cell; 1992 Dec; 3(12):1339-52. PubMed ID: 1493333
[TBL] [Abstract][Full Text] [Related]
8. Glucocorticoid ligands specify different interactions with NF-kappaB by allosteric effects on the glucocorticoid receptor DNA binding domain.
Garside H; Stevens A; Farrow S; Normand C; Houle B; Berry A; Maschera B; Ray D
J Biol Chem; 2004 Nov; 279(48):50050-9. PubMed ID: 15355994
[TBL] [Abstract][Full Text] [Related]
9. Dexamethasone inhibits IL-1 beta gene expression in LPS-stimulated RAW 264.7 cells by blocking NF-kappa B/Rel and AP-1 activation.
Jeon YJ; Han SH; Lee YW; Lee M; Yang KH; Kim HM
Immunopharmacology; 2000 Jul; 48(2):173-83. PubMed ID: 10936515
[TBL] [Abstract][Full Text] [Related]
10. Selective modulation of the glucocorticoid receptor can distinguish between transrepression of NF-κB and AP-1.
De Bosscher K; Beck IM; Dejager L; Bougarne N; Gaigneaux A; Chateauvieux S; Ratman D; Bracke M; Tavernier J; Vanden Berghe W; Libert C; Diederich M; Haegeman G
Cell Mol Life Sci; 2014 Jan; 71(1):143-63. PubMed ID: 23784308
[TBL] [Abstract][Full Text] [Related]
11. A new function for the C-terminal zinc finger of the glucocorticoid receptor. Repression of RelA transactivation.
Liden J; Delaunay F; Rafter I; Gustafsson J; Okret S
J Biol Chem; 1997 Aug; 272(34):21467-72. PubMed ID: 9261164
[TBL] [Abstract][Full Text] [Related]
12. Cross-talk between nuclear factor-kappa B and the steroid hormone receptors: mechanisms of mutual antagonism.
McKay LI; Cidlowski JA
Mol Endocrinol; 1998 Jan; 12(1):45-56. PubMed ID: 9440809
[TBL] [Abstract][Full Text] [Related]
13. Glucocorticoid repression of AP-1 is not mediated by competition for nuclear coactivators.
De Bosscher K; Vanden Berghe W; Haegeman G
Mol Endocrinol; 2001 Feb; 15(2):219-27. PubMed ID: 11158329
[TBL] [Abstract][Full Text] [Related]
14. Glucocorticoids inhibit the induction of nitric oxide synthase II by down-regulating cytokine-induced activity of transcription factor nuclear factor-kappa B.
Kleinert H; Euchenhofer C; Ihrig-Biedert I; Förstermann U
Mol Pharmacol; 1996 Jan; 49(1):15-21. PubMed ID: 8569701
[TBL] [Abstract][Full Text] [Related]
15. Ethanol-mediated regulation of transcription factors in immunocompetent cells.
Szabo G; Mandrekar P
Front Biosci; 2002 May; 7():a80-9. PubMed ID: 11991856
[TBL] [Abstract][Full Text] [Related]
16. Hormone-independent repression of AP-1-inducible collagenase promoter activity by glucocorticoid receptors.
Liu W; Hillmann AG; Harmon JM
Mol Cell Biol; 1995 Feb; 15(2):1005-13. PubMed ID: 7823916
[TBL] [Abstract][Full Text] [Related]
17. Physical association and functional antagonism between the p65 subunit of transcription factor NF-kappa B and the glucocorticoid receptor.
Ray A; Prefontaine KE
Proc Natl Acad Sci U S A; 1994 Jan; 91(2):752-6. PubMed ID: 8290595
[TBL] [Abstract][Full Text] [Related]
18. Cytosolic glucocorticoid receptor interaction with nuclear factor-kappa B proteins in rat liver cells.
Widén C; Gustafsson JA; Wikström AC
Biochem J; 2003 Jul; 373(Pt 1):211-20. PubMed ID: 12672265
[TBL] [Abstract][Full Text] [Related]
19. Repression of p65 transcriptional activation by the glucocorticoid receptor in the absence of receptor-coactivator interactions.
Wu J; Li Y; Dietz J; Lala DS
Mol Endocrinol; 2004 Jan; 18(1):53-62. PubMed ID: 14551261
[TBL] [Abstract][Full Text] [Related]
20. Glucocorticoid receptor signaling in a bronchial epithelial cell line.
LeVan TD; Behr FD; Adkins KK; Miesfeld RL; Bloom JW
Am J Physiol; 1997 May; 272(5 Pt 1):L838-43. PubMed ID: 9176246
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
